Europe EditionAre Antiplatelet Treatments or Anticoagulation Treatments Better for People Who Have Heart Failure with a Normal Heart Rhythm?
2 Articles
2 Articles
Researchers from the Arnau de Vilanova University Hospital and the NUTRIMMIC group of the IRBLleida have presented the results of a pioneering clinical trial with innovative oral iron formulations for patients with heart failure with preserved ejection fraction (HFpEF). This condition affects 50% of patients with heart failure and, until now, had little effective treatment. The study, recognized as innovative at the European Heart Failure Congre…
Are antiplatelet treatments or anticoagulation treatments better for people who have heart failure with a normal heart rhythm?
Are antiplatelet treatments or anticoagulation treatments better for people who have heart failure with a normal heart rhythm? Key messages – For people who have heart failure with a normal heart rhythm, there seems to be little to no advantage of warfarin (an anticoagulant: a medicine which prevents blood clotting by blocking proteins) over antiplatelet medicines like aspirin (which prevent blood clotting by blocking platelets). – Treatment wit…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
